1. Deficiency in ST2 signaling ameliorates RSV-associated pulmonary hypertension.
- Author
-
Luan D. Vu, Saravia, Jordy, Jaligama, Sridhar, Baboeram Panday, Rajshri V., Sullivan, Ryan D., Mancarella, Salvatore, Cormier, Stephania A., and Dai Kimura
- Subjects
PULMONARY hypertension ,NITRIC-oxide synthases ,LABORATORY mice ,RESPIRATORY syncytial virus ,SYSTOLIC blood pressure - Abstract
Pulmonary hypertension (PH) observed during respiratory syncytial virus (RSV) bronchiolitis is associated with morbidity and mortality, especially in children with congenital heart disease. Yet, the pathophysiological mechanisms of RSV-associated PH remain unclear. Therefore, this study aimed to investigate the pathophysiological mechanism of RSV-associated PH. We used a translational mouse model of RSV-associated PH, in which wild-type (WT) and suppression of tumorigenicity 2 (ST2) knockout neonatal mice were infected with RSV at 5 days old and reinfected 4 wk later. The development of PH in WT mice following RSV reinfection was evidenced by elevated right ventricle systolic pressure, shortened pulmonary artery acceleration time (PAT), and decreased PAT/ejection time (ET) ratio. It coincided with the augmentation of periostin and IL-13 expression and increased arginase bioactivity by both arginase 1 and 2 as well as induction of nitric oxide synthase (NOS) uncoupling. Absence of ST2 signaling prevented RSV-reinfected mice from developing PH by suppressing NOS uncoupling. In summary, ST2 signaling was involved in the development of RSV-associated PH. ST2 signaling inhibition may be a novel therapeutic target for RSV-associated PH. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF